Filing Details
- Accession Number:
- 0001209191-18-058707
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-15 16:04:29
- Reporting Period:
- 2018-11-13
- Accepted Time:
- 2018-11-15 16:04:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337798 | Bradley G Cole | 301 Penobscot Drive Redwood City CA 94063 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-13 | 5,000 | $17.18 | 50,372 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-11-13 | 3,576 | $22.98 | 53,948 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-11-13 | 2,817 | $78.29 | 51,131 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-13 | 600 | $79.30 | 50,531 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-13 | 1,083 | $80.32 | 49,448 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-13 | 500 | $81.60 | 48,948 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-13 | 1,976 | $78.34 | 46,972 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-13 | 900 | $80.23 | 46,072 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-13 | 300 | $81.46 | 45,772 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-13 | 400 | $79.20 | 45,372 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-11-13 | 5,000 | $0.00 | 5,000 | $17.18 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-11-13 | 3,576 | $0.00 | 3,576 | $22.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 41,471 | 2020-02-18 | No | 4 | M | Direct | |
| 56,424 | 2021-01-27 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 16,534 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plans adopted by the reporting person on June 4, 2018 and August 23, 2018.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $77.87 to $78.71.
- Represents weighted average sale price. Actual sale prices ranged from $78.93 to $79.61.
- Represents weighted average sale price. Actual sale prices ranged from $79.93 to $80.70.
- Represents weighted average sale price. Actual sale prices ranged from $81.13 to $82.08.
- Represents weighted average sale price. Actual sale prices ranged from $77.90 to $78.80.
- Represents weighted average sale price. Actual sale prices ranged from $79.95 to $80.65.
- Represents weighted average sale price. Actual sale prices ranged from $81.12 to $82.08.
- Represents weighted average sale price. Actual sale prices ranged from $78.93 to $79.62.
- The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter.
- The option became exercisable as to 25% of the shares on January 27, 2012, and became exercisable as to 1/48th of the shares each full month thereafter.
Billionaire Hedge Funds
